Published in Vaccine Weekly, February 20th, 1995
In a recent study published in the journal Vaccine, Tam and colleagues found that the lipid-linked synthetic peptide dendrimer is effective in initiating cellular and humoral immunity both systemically and at mucosal sites in the body.
"The results described in this study are, to our knowledge, the first report that an orally administered synthetic antigenic peptide can evoke humoral and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1995-02-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.